Novartis investors turn spotlight on M&A after trial setbacks
By Bhanvi Satija, Oliver Hirt and Marleen Kaesebier LONDON/ZURICH, Sept 11 (Reuters) – Novartis investors are set to step up scrutiny of the Swiss group’s dealmaking strategy after setbacks to…









